Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)

Plain-language summary

This observational study aims to follow patients with laminopathies and emerinopathies who carry a proven disease-causing mutation in the LMNA and/or EMD gene. It enrolls patients who are regularly followed in France and provide consent. This is a study with no assigned phase and it is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Pitié-Salpêtrière Hospital

Start date

7/11/2013

Estimated completion

7/11/2033

Countries

France

Related genes

Locations

• Angers, France
• Strasbourg, France
• Marseille, France
• Caen, France
• Brest, France
• Nîmes, France
• Bordeaux, France
• Toulouse, France
• Montpellier, France
• Rennes, France
• Tours, France
• Lille, France
• Nantes, France
• Lyon, France
• Nancy, France
• Paris, France
• Paris, France
• Paris, France
• Paris, France
• Paris, France
• Paris, France
• Paris, France
• Clermont-Ferrand, France
• Rouen, France
• Créteil, France
• Garches, France
• Grenoble, France
• Paris, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Presence of a proven pathogenic LMNA and/or EMD gene mutation
* Regular followup in France.
* Signed informed consent

Exclusion Criteria:

-Refusal to sign an informed consent.